Catalyst Wire Dossier Catalyst Wire Dossier

Shingrix

recombinant zoster vaccine, adjuvanted · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

38 regulatory and trial events tracked for Shingrix, covering 2016-02-10 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Comprehensive Characterization of Immune Response Induced by Adjuvanted Glycoprotein E (gE)-Based Recombinant VAccine Zoster in Vulnerable Population Receiving ImmunOmodulaNt Therapies

See pricing